期刊文献+

原发ANCA相关性小血管炎发生慢性肾功能衰竭的临床分析 被引量:4

Clinical study on primary ANCA associated vasculitis induced chronic renal failure
下载PDF
导出
摘要 目的探讨原发ANCA相关性小血管炎发生慢性肾功能衰竭的危险因素。方法 74例确诊原发ANCA相关小血管炎患者,跟踪随访至少1年,以是否进入慢性肾功能衰竭分为肾功能正常组(对照组)和慢性肾功能衰竭组(观察组),对比分析两组患者的临床资料,探寻肾功能预后不良的相关危险因素。结果 74例患者中1年内发生慢性肾功能衰竭43例(58.1%),与肾功能正常组患者相比:(1)贫血、消化道症状的发生率在慢性肾功能衰竭组中较高(P<0.05);(2)尿蛋白水平、肾穿时的血清尿素氮水平、血清肌酐水平、血清尿酸水平在慢性肾功能衰竭组是增高的(P<0.05);(3)两组患者收缩压、舒张压、血红蛋白、红细胞计数、肾脏病理慢性评分差异有统计学意义(P<0.05),均在慢性肾功能衰竭组中增高。结论 ANCA相关小血管炎发生慢性肾功能衰竭可能相关的危险因素:消化道症状,尿蛋白水平,血尿素氮、肌酐、尿酸水平,高血压,贫血和肾脏慢性病理改变。 Objective To investigate the risk factors of primary ANCA associated vasculitis (AAV) induced chronic renal failure (CRF). Methods Seventy - four patients with confirmed primary ANCA associated vasculitis were followed up for one year, and were assigned into chronic renal failure group and normal renal function group according to renal function after followed - up. Clinical data were analysis of the risk faetors associated with poor renal prognosis. Resuits (1) The prevalence of chronic renal failure was 58. 1% , while there were significantly higher rates of anemia and gastrointestinal symptoms in chronic renal failure group ( P 〈 0. 05 ). (2) Significantly higher urinary protein excretion, serum urea nitrogen, serum creatinine and serum uric were observed in CRF group ( P 〈 0. 05 ). (3) Significant increase of in blood pressure, hemoglobin, red blood cell count and chronic score of renal were revealed in CRF group ( P 〈 0. 05 ). Conclusion Gastrointestinal symptoms, urinary protein excretion, renal dysfunction, hypertension, anemia and chronic renal pathological changes are risk factors of AAV induced CRF.
出处 《广东医学》 CAS CSCD 北大核心 2011年第4期451-454,共4页 Guangdong Medical Journal
基金 广西青年科学基金资助项目(编号:桂科青0728060) 广西医科大学校博士启动基金资助项目(编号:308019) 广西卫生厅自筹课题(编号:z200788)
关键词 ANCA相关性小血管炎 慢性 肾功能衰竭 临床 ANCA associated vasculitis chronic renal failure clinic
  • 相关文献

参考文献12

  • 1FALK R J,JENNETTE J C.ANCA disease:where is this field heading?[J].J Am Soc Nephrol,2010,21(5):745-752.
  • 2JENNETTE J C,FALK R J,ANDRASSY K,et al.Nomenclature of systemic vasculitides.Proposal of an international consensus conference[J].Arthritis Rheum,1994,37(2):187-192.
  • 3CHURG J,BERNSTEIN J,GLASSOCK R J.Renal disease classification and atlas of glomerular-disease[M].Second edition.New York:Ikagu Shoin,1995:45-47.
  • 4HOGAN S L,FALK P J,CHIN H,et al.Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis[J].Ann Intern Med,2005,143(9):621-631.
  • 5陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2009:274.
  • 6ZYCINSKA K,WARDYN K A,TYSZKO P,et al.Analysis of early death based on the prediction model in Wegener's granulomatosis with pulmonary and renal involvement[J].J Physiol Pharmacol,2007,Suppl 5(Pt 2):829-837.
  • 7GUILLEVIN L,LHOTE F,GALLAIS V,et al.Gastrointestinal tract involvement in polyarteritis nodosa and Churg-Strauss syndrome[J].Ann Med Int(Paris),1995,146(4):260-267.
  • 8PAGNOUX C,MAHR A,COHEN P,et al.Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides:analysis of 62 patients with polyarteritis nodosa,microscopic polyangiitis,Wegener granulomatosis,Churg-Strauss syndrome,or rheumatoid arthritis-associated vasculitis[J].Medicine(Baltirnore),2005,84(2):115-128.
  • 9KAPLAN PAVLOVCIC S,CERK K,KVEDER R,et al.Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients[J].Nephrol Dial Transplant,2003,18(Suppl 5):5-7.
  • 10YU F,CHEN M,WANG S X,et al.Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney[J].Nephrology(Carlton),2007,12(1):74-80.

二级参考文献19

  • 1[3]Franssen CFM,Stegenman CA,Oost-Kort WW,et al.Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis.J Am Soc Nephrol,1998,9:1915
  • 2[4]Asarod K ,Iversen BM,Hammerstrom J,et al.Wegener's granulomatosis:clinical course in 108 patients with renal involvement.Nephrol Dial Transplant,2000,15:611
  • 3[5]Gans ROB,Kuizinga MC,Goldschmeding R,et al.Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies.Nephron,1993,64:182
  • 4[6]Slot MC,Tervaert JWC,Franssen CFM, et al.Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement.Kidney Intern,2003,63:670
  • 5[7]Hogen SL,Nachmen PH ,Wilkman AS,et al:Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-assiociated microscopic polyangiitis and glomerulonephritis.J Am Soc Nephrol,1996,7:23
  • 6[9]Jeneette JC,Falk FC,Andrassy Ket al.Nomenclasture of systemic vasculitides:the proposal of an international consensus conference.Arthritis Rheum,1994,37:187
  • 7[10]Falk RJ, Hogan S, Garey TS,et al.Clinical course antineurophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis.Ann Intern Med,1990,113:656
  • 8[11]Savage COS,Harper L,Adu A. .Primary systemic vasculitis.Lancet,1997,349:553
  • 9[12]Gaskin G,Jayne D. Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis.J Am Soc Nephrol,2002,13(Suppl S):2A
  • 10[13]AlènRa vizjak,Toma? Rott,Mira Koselij-Kajtna,et al.Histologic and immumohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis, 2003,41:539

共引文献269

同被引文献42

  • 1林华志.原发性小血管炎肾损害患者的护理[J].临床医学,2007,27(4):93-94. 被引量:2
  • 2Greaves SC,Gamble GD,Collins JF,et al.Determinants of left ventricular hypertrophy and systolic dysfunction in chronic renal failure[J].Am J Kidney Dis,1994,24(5):768-776.
  • 3Washio M,Okuda S,Mizoue T,et al.Risk factors for left ventricular hypertrophy in chronic hemodialysis patients[J].Clin Nephrol,1997,47(6):362-366.
  • 4Ronald MA,Henry RM,Pite Y,et al.Mild renal insufficiency is associated with increased cardiovascular mortality:the hoorn study[J].Kidney Int,2002,62(4):1402-1407.
  • 5Eschbach JW.Current concepts of anemia management in chronic renal failure:impact of NKF-DOQI[J].Semin Nephrol,2010,20(4):320-329.
  • 6Locatelli F,Pisoni RL,Combe C,et al.Anaemia in haemodialysis patients of five european countries:association with morbidity and mortality in the dialysis outcomes and practice patterns study(DOPPS)[J].Nephrol Dial Transplant,2011,19(1):121-132.
  • 7Portolés J,López Gómez JM,Aljama PA.Prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients:the mar study[J].Nephrol Dial Transplant,2007,22(2):500-507.
  • 8Gilbertson DT,Ebben JP,Foley RN,et al.Hemoglobin level variability:associations with mortality[J].Clin J Am Soc Nephrol,2008,3(1):133-138.
  • 9Plantinga LC,Fink NE,Jaar BG,et al.Relation between level or change of hemoglobin and generic and disease-specific quality of life in h dialysis[J].Qual Life Res,2007,16(5):755-765.
  • 10Frank H,Heusser K,Hffken B,et al.Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients[J].Kidney Int,2011,66(2):832-840.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部